Circulation Journal · 2006 · 71 citations · 26 references
MedicinePreventive MedicineClinical NutritionHuman NutritionMetabolic PhysiologyCardiovascular DiseaseMetabolic SyndromeC-reactive Protein TestingCardiovascular Disease PrevalenceCut PointsHigh-risk Patient IdentificationLow Body Mass IndexMetabolic Risk AssessmentMetabolic Syndrome Risk AssessmentMetabolic Syndrome Screening
BACKGROUND: C-reactive protein (CRP) independently predicts cardiovascular disease (CVD) and is considered to be part of metabolic syndrome (MS). The concentration of CRP are proposed to be <1.0 mg/L as low risk, 1.0 to 3.0 mg/L as intermediate risk, and >3.0 mg/L as high risk for CVD in Western society. METHODS AND RESULTS: Apparently healthy 179 men and 166 women were categorized with modified National Cholesterol Education Program Adult Treatment Panel III criteria (body mass index > or = 25 in place of abdominal obesity) for defining MS. The cut-off points of CRP were evaluated for both MS defined by impaired fasting glucose criteria of > or = 110 mg/dl (MS110) and > or = 100 mg/dl (MS100), separately by sex. The optimal cut-off point of CRP was 0.65 mg/L in all subgroups. The sensitivity and specificity of this CRP value for male MS100, female MS100, male MS110, and female MS110 were 0.650 and 0.626, 1.000 and 0.771, 0.739 and 0.609, and 1.000 and 0.756, respectively. CONCLUSIONS: The optimal cut-off point of CRP for MS might be 0.65 mg/L in Japan and this value can be useful in routine clinical practice and studies on MS.
26
Prediction of Coronary Heart Disease Using Risk Factor Categories
Peter W.F. Wilson, Ralph B. D’Agostino, Daniel Levy et al. · Circulation · 1998 · 9.6K citations
The metabolic syndrome—a new worldwide definition
K. G. M. M. Alberti, Paul Zimmet, Jonathan E. Shaw · The Lancet · 2005 · 9.3K citations
Markers of Inflammation and Cardiovascular Disease
Thomas A. Pearson, George A. Mensah, R. Wayne Alexander et al. · Circulation · 2003 · 6.4K citations · Full text
Chronic Subclinical Inflammation as Part of the Insulin Resistance Syndrome
Andreas Festa, Ralph B. D’Agostino, George Howard et al. · Circulation · 2000 · 2.4K citations
Medicine, Endocrinology, Physiology +17
C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events
Paul M. Ridker, Julie E. Buring, Nancy R. Cook et al. · Circulation · 2003 · 2.3K citations